|
|
|
-
2024 Estimated Capital Gain Distributions
Certain First Trust First Trust Exchange-Traded Funds are expected to pay a long-term capital gain distribution in December. For a list of exchange-traded funds expected to pay a long-term capital gain distribution, please click here. Also, certain First Trust Exchange-Traded Funds are expected to pay short-term capital gain distributions in December. For a list of exchange-traded funds expected to pay a short-term capital gain distribution, please click here. Final determination of the source and tax status of all distributions paid in the current year are to be made after year-end and could differ from the expectations noted above.
Investment Objective/Strategy - The First Trust Mid Cap Growth AlphaDEX® Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an equity index called the Nasdaq AlphaDEX® Mid Cap Growth™ Index.
There can be no assurance that the Fund's investment objectives will be achieved.
- The Index is an "enhanced" index created and administered by Nasdaq, Inc. ("Nasdaq") which employs the AlphaDEX® stock selection methodology to select stocks from the Nasdaq US 600 Mid Cap Growth™ Index that meet certain criteria.
- Nasdaq constructs the Index by ranking the eligible stocks from the Nasdaq US 600 Mid Cap Growth™ Index on growth factors including 3-, 6- and 12- month price appreciation, sales to price and one year sales growth, and separately on value factors including book value to price, cash flow to price and return on assets. All stocks are ranked on the sum of ranks for the growth factors and, separately, all stocks are ranked on the sum of ranks for the value factors. A stock must have data for all growth and/or value factors to receive a rank for that style.
- Each stock receives either its growth or value score as its selection score based on its style designation as determined by Nasdaq. Only those stocks designated as growth stocks are eligible for the portfolio.
- The top 225 stocks based on the selection score determined in the previous step comprise the "selected stocks". The selected stocks are divided into quintiles based on their rankings and the top ranked quintiles receive a higher weight within the index. The stocks are equally-weighted within each quintile.
- The Index is reconstituted and rebalanced quarterly.
Ticker | FNY |
Fund Type | Mid Cap Growth |
Investment Advisor | First Trust Advisors L.P. |
Investor Servicing Agent | Bank of New York Mellon Corp |
CUSIP | 33737M102 |
ISIN | US33737M1027 |
Intraday NAV | FNYIV |
Fiscal Year-End | 07/31 |
Exchange | Nasdaq |
Inception | 4/19/2011 |
Inception Price | $20.17 |
Inception NAV | $20.17 |
Rebalance Frequency | Quarterly |
Total Expense Ratio* | 0.70% |
* As of 12/1/2023
Closing NAV1 | $84.39 |
Closing Market Price2 | $84.41 |
Bid/Ask Midpoint | $84.43 |
Bid/Ask Premium | 0.05% |
30-Day Median Bid/Ask Spread3 | 0.14% |
Total Net Assets | $383,963,774 |
Outstanding Shares | 4,550,002 |
Daily Volume | 9,348 |
Average 30-Day Daily Volume | 12,792 |
Closing Market Price 52-Week High/Low | $87.00 / $60.49 |
Closing NAV 52-Week High/Low | $87.03 / $60.50 |
Number of Holdings (excluding cash) | 225 |
Holding |
Percent |
Affirm Holdings, Inc. (Class A) |
1.08% |
SoFi Technologies, Inc. |
1.04% |
Natera, Inc. |
0.92% |
FTAI Aviation Ltd. |
0.90% |
Sprouts Farmers Market, Inc. |
0.90% |
Q2 Holdings, Inc. |
0.89% |
Axos Financial, Inc. |
0.88% |
Leonardo DRS, Inc. |
0.86% |
Comfort Systems USA, Inc. |
0.85% |
Corcept Therapeutics Incorporated |
0.85% |
* Excluding cash.
Holdings are subject to change.
Past performance is not indicative of future results.
Among 512 funds in the Mid-Cap Growth category. This fund was rated 4 stars/512 funds (3 years), 4 stars/477 funds (5 years), 4 stars/380 funds (10 years) based on risk adjusted returns.
Maximum Market Cap. | $27,072 |
Median Market Cap. | $7,580 |
Minimum Market Cap. | $2,686 |
Price/Earnings | 25.95 |
Price/Book | 4.13 |
Price/Cash Flow | 18.83 |
Price/Sales | 3.20 |
|
2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Days Traded at Premium |
92 |
21 |
22 |
9 |
Days Traded at Discount |
158 |
40 |
41 |
55 |
Industrials
|
21.61%
|
Financials
|
17.62%
|
Health Care
|
14.86%
|
Information Technology
|
14.03%
|
Consumer Discretionary
|
12.82%
|
Real Estate
|
5.90%
|
Materials
|
5.35%
|
Consumer Staples
|
3.41%
|
Communication Services
|
1.63%
|
Energy
|
1.39%
|
Utilities
|
1.38%
|
|
|
Tracking Index: Nasdaq AlphaDEX® Mid Cap Growth™ Index
|
Standard Deviation |
Alpha |
Beta |
Sharpe Ratio |
Correlation |
FNY |
22.49% |
-1.31 |
1.07 |
0.02 |
0.98 |
S&P MidCap 400® Growth Index |
20.43% |
--- |
1.00 |
0.08 |
1.00 |
Standard Deviation is a measure of price variability (risk). Alpha is an indication of how much an investment outperforms or underperforms
on a risk-adjusted basis relative to its benchmark.Beta is a measure of price variability relative to the market. Sharpe Ratio is a measure
of excess reward per unit of volatility. Correlation is a measure of the similarity of performance.
Nasdaq US 600 Mid Cap Growth™ Index - The Index is a float modified market capitalization weighted index that includes growth securities from the Nasdaq US 600 Mid Cap™ Index. Russell 3000® Index - The Index is comprised of the 3000 largest and most liquid stocks based and traded in the U.S. S&P MidCap 400® Growth Index - The Index contains those stocks with growth characteristics from the 400 stocks used to measure mid cap U.S. stock market performance.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|